Growth Hormone & Anti-Ageing

CJC-1295 + Ipamorelin Stack Protocol: The Gold Standard GH Combination (2026)

Underground Biohacking|May 8, 2026|14 min read

CJC-1295 and ipamorelin stack two vials GH pulse protocol on dark tactical lab surface

What Is the CJC-1295 Ipamorelin Stack?

The CJC-1295 ipamorelin stack combines a GHRH analogue with a selective GH secretagogue to amplify natural growth hormone pulses beyond what either compound achieves alone. Research confirms this two-vial protocol produces synergistic GH and IGF-1 elevation, making it the gold standard GH combination for body composition, recovery, and sleep quality in 2026.

If you have spent any time researching growth hormone optimisation, you will have encountered these two peptides mentioned together repeatedly. That is not coincidence or marketing convention. The pairing is mechanistically justified, CJC-1295 and ipamorelin operate through entirely different receptor pathways, and when deployed together, their effects multiply rather than simply add.

This guide covers the full stack protocol: how the two-vial system works at the receptor level, the GH pulse pattern it generates, precise dosing for both the no-DAC and DAC versions, timing strategy, cycling, and what to realistically expect across an 8-12 week run. For the standalone mechanism and dosing breakdown of the GHRH analogue alone, see our CJC-1295 Complete Guide.

Get The Peptide Edge

Bibliography

Teichman SL et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab. 2006. PMID 16757546
Johansen PB et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1999. PMID 10373343
Alba M et al. GHRH and GHRP-2 administration in healthy elderly men: synergistic effects on GH secretion. Clin Endocrinol. 1998. PMID 9849015
Ghigo E et al. Growth hormone secretagogues: clinical aspects. Ann Endocrinol. 2008. PMID 18430549

Important Disclaimer

This content is for educational purposes only. These compounds are intended for research use. Nothing here is medical advice.

CJC-1295 and ipamorelin are not FDA-approved medications. This protocol carries potential risks, particularly for individuals with metabolic conditions, cancer history, or other health considerations. Always work with a qualified clinician before making changes to your health protocol. A practitioner can evaluate your individual circumstances, order baseline testing, and monitor your progress through the run.

Trusted Source

If you are researching this stack, Real Peptides is the supplier I recommend — independent lab verification, consistent purity, and the compounds available for this protocol.

View on Real Peptides

Using this link supports the site at no extra cost to you.

Run a 90-Day Body Composition Plan Without Guesswork

CJC-1295/Ipamorelin is one tool. The Peptide Edge is a 90-day framework for men 35+. Pick body composition as your path, run a structured block, and track outcomes before changing anything. Includes 12-week starter blueprints, dosing and setup cheat sheets, a readiness checklist, a labwork and monitoring guide, and tracking sheets. $49 with a 30-day money-back guarantee.

$49

Get The Peptide Edge

Need supplies?

Source CJC-1295/Ipamorelin from a trusted supplier.

Real Peptides →

Share this article

Frequently Asked Questions

What is the CJC-1295 ipamorelin stack and why do these two peptides work together?

CJC-1295 is a GHRH analogue that primes the pituitary for GH release and expands secretory capacity. Ipamorelin is a selective GHRP that triggers acute GH pulses without raising cortisol. Combined, they produce synergistic GH and IGF-1 elevation that neither compound achieves independently, confirmed in GHRH plus GHRP combination trials.

What is the correct dose for CJC-1295 and ipamorelin?

No-DAC protocol: 100-200 mcg CJC-1295 plus 200-300 mcg ipamorelin per injection, 2-3 times daily in a fasted state. DAC protocol: 1-2 mg CJC-1295 once weekly plus 100-300 mcg ipamorelin daily. Start at the lower end and assess your response after 1-2 weeks before increasing.

Should I use CJC-1295 with or without DAC?

No-DAC (Modified GRF 1-29) has a 30 minute to 2 hour half-life, creates pulsatile GH release that mirrors natural physiology, and requires 2-3 daily injections. DAC extends half-life to 6-8 days and requires one weekly injection but creates sustained rather than pulsatile GH elevation. Most practitioners prefer no-DAC for active men and athletic recovery goals.

When is the best time to inject CJC-1295 and ipamorelin?

Always inject in a fasted state, at least 2 hours after your last meal. The three key windows are morning fasted, pre-workout (optional), and 30-60 minutes before bed. The pre-bed injection is particularly valuable as it aligns with your natural GH peak during slow-wave sleep and directly supports overnight recovery.

How long does it take to see results from the CJC-1295 ipamorelin stack?

Sleep quality typically improves within 1-2 weeks. Recovery between training sessions improves measurably by weeks 3-4. Visible body composition changes emerge after 4-6 weeks of consistent training and appropriate nutrition. The full compounding benefit of the protocol develops over an 8-12 week run.

What side effects should I expect from this stack?

Common effects include temporary water retention in weeks 1-2, mild tingling in extremities, occasional vivid dreams, and brief head rush after injection. Ipamorelin does not significantly raise cortisol or prolactin at standard doses, unlike older GHRPs. Most effects resolve within 2 weeks. Monitor fasting glucose and IGF-1 through the protocol.

Get the Pre-Protocol Checklist

Free checklist plus weekly protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.